Related Articles
Reports from the field
I’d like to think so! Elekta is perfectly sized and positioned to achieve the balance of customer intimacy, product innovations and business results. It’s the “Goldilocks” analogy – an organization with just the right size, fit and balance. Elekta is a global company and brand with over $1.4 billion in revenue, and at the same…
To celebrate the International Day of Women and Girls in Science, we have brought together three female Elekta leaders to discuss their perspectives on gender equality in science-based roles. Here you’ll find out what the current challenges are and what can be done to entice more women to work in this field. Giulia Thompson, PhD,…
March 2020 saw the greatest global shift to homeworking it has ever seen. While businesses rapidly adapted to this situation, what wasn’t immediately obvious was the impact the pandemic would have on employees’ health and wellbeing. Ami Meech, Elekta’s Vice President of HR Americas and Oncology Informatics Solutions, discusses how her team quickly reacted to…
While the rate of growth in the use of Radiation Therapy (RT) in the Asia Pacific region currently exceeds the overall global average growth rate, with a compound annual growth rate of 6.82 percent compared to six percent, globally1, the difference in availability of high-tech cancer care between the ‘East’ and the ‘West’ is still…
Covid-19 has delayed the diagnosis and treatment of cancer in hospitals around the world. Lockdowns and travel restrictions have prevented the shipping, installation, clinical use and servicing of life-saving radiation therapy systems. Despite this, the West African country Togo has been remarkable in launching the county’s first linac. According to the WHO, approximately 70 percent of…
The intense interest in the potential of MR-guided radiation therapy spurred researchers to cite – in great numbers in Physics in Medicine & Biology (PMB) – a paper describing the 2017 first-in-human proof-of-concept study involving the prototype of Elekta Unity, the world’s first high-field (1.5T) MR-Linac. The 217 citations of the paper: “First patients treated…
When Serpil received her cancer diagnosis at 38, her thoughts immediately turned to her young children. Would her family be able to continue exploring cities, going on picnics or visiting her relatives in Turkey or her husband’s in Greece? And how would Covid-19 affect her access to cancer care? Serpil’s son had just stopped nursing…
It was already the most advanced magnetic resonance radiation therapy (MR/RT) system in the world when launched in 2018, nevertheless, Elekta’s MR-Linac, Elekta Unity, continues to evolve, and further sets us apart from our competitors. Motion related image artifacts are a common challenge with free-breathing MRI. The latest product release on Elekta Unity enables 3D…
As a leading innovator of precision radiation therapy solutions, Elekta is committed to ensuring that every patient has access to the best cancer care possible.
The products and product clinical indications for use described within FOCUS may not have clearance or registration in certain countries. Please consult Elekta in your country for questions concerning a product or clinical use subject. This site may contain information provided by third party sources to Elekta that does not necessarily represent the views of Elekta. Individuals interviewed provided information based on their personal experience and were not compensated for their participation. Accordingly, third party information contained in this site is provided "as is" with no guarantees of completeness, accuracy, usefulness, or timeliness.
© 2022 Elekta | FOCUS Magazine. | Privacy Policy | Cookies
